Get started
Work

Supplementary Table S1 from A pilot study of neoadjuvant nivolumab, ipilimumab and intralesional oncolytic virotherapy for HER2-negative breast cancer

Year: 2023
Type: supplementary-materials
Abstract: Representativeness of Study Participants
DOI: 10.1158/2767-9764.23791811.v1
Authors: Vina P Nguyen, Katie M. Campbell, Theodore S Nowicki, Nila Elumalai, Egmidio Medina, Ignacio Baselga-Carretero, Maggie L DiNome, Helena R. Chang, Denise K Oseguera, Antoni Ribas, John A. Glaspy
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4385356757
Cites:
Cited by:
Related to: 10